In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from the seven pharma executives who will attend — and why their rhetoric rings hollow when measured against their companies’ track record.
In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from…
In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from…
In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from…
As bipartisan momentum to hold Big Pharma accountable and take action on out-of-control drug prices continues to build, the U.S. Senate Committee on Finance is scheduled to question the executives…
For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] On Tuesday, the U.S. House Committee on Ways & Means held the third hearing of the new Congress in under one…
The momentum in Congress to act on out-of-control drug prices will continue to build tomorrow, February 12, with a U.S. House Ways and Means Committee hearing entitled, “The Cost of Rising…
NBC News Ben Kesslen February 7, 2019 “I don’t think I would be alive today” without the very-expensive drug, Will Schuller told NBC News. When Will Schuller was an 18-year-old senior in…
For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected] Following the reintroduction of the bipartisan Creating and Restoring Equal Access To Equivalent Samples (CREATES)…
For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released the following statement in…